The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 06, 2022
Filed:
Jan. 24, 2018
Applicant:
Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, CN;
Inventors:
Lingyun Wu, Shanghai, CN;
Li Zhang, Shanghai, CN;
Lele Zhao, Shanghai, CN;
Jianjun Sun, Shanghai, CN;
Zhaoguo Chen, Shanghai, CN;
Jian Li, Shanghai, CN;
Shuhui Chen, Shanghai, CN;
Assignee:
MEDSHINE DISCOVERY INC., Jiangsu, CN;
Primary Examiner:
Int. Cl.
CPC ...
C07D 207/09 (2006.01); C07D 207/335 (2006.01); C07D 209/44 (2006.01); C07D 211/18 (2006.01); C07D 211/34 (2006.01); C07D 213/38 (2006.01); C07D 217/26 (2006.01); C07D 223/16 (2006.01); C07D 231/12 (2006.01); C07D 233/64 (2006.01); C07D 249/06 (2006.01); A61K 31/4245 (2006.01); A61P 35/00 (2006.01); A61K 33/243 (2019.01); A61K 31/135 (2006.01); A61K 31/165 (2006.01); A61K 31/277 (2006.01); A61K 31/40 (2006.01); A61K 31/4035 (2006.01); A61K 31/41 (2006.01); A61K 31/415 (2006.01); A61K 31/417 (2006.01); A61K 31/4188 (2006.01); A61K 31/4192 (2006.01); A61K 31/4196 (2006.01); A61K 31/422 (2006.01); A61K 31/423 (2006.01); A61K 31/426 (2006.01); A61K 31/428 (2006.01); A61K 31/437 (2006.01); A61K 31/4375 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/451 (2006.01); A61K 31/4545 (2006.01); A61K 31/472 (2006.01); A61K 31/519 (2006.01); A61K 31/55 (2006.01); C07C 211/40 (2006.01); C07C 233/58 (2006.01); C07C 255/46 (2006.01); C07D 249/08 (2006.01); C07D 257/04 (2006.01); C07D 261/20 (2006.01); C07D 263/56 (2006.01); C07D 271/06 (2006.01); C07D 277/28 (2006.01); C07D 413/04 (2006.01); C07D 413/06 (2006.01); C07D 413/10 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4245 (2013.01); A61K 31/135 (2013.01); A61K 31/165 (2013.01); A61K 31/277 (2013.01); A61K 31/40 (2013.01); A61K 31/4035 (2013.01); A61K 31/41 (2013.01); A61K 31/415 (2013.01); A61K 31/417 (2013.01); A61K 31/4188 (2013.01); A61K 31/4192 (2013.01); A61K 31/4196 (2013.01); A61K 31/422 (2013.01); A61K 31/423 (2013.01); A61K 31/426 (2013.01); A61K 31/428 (2013.01); A61K 31/437 (2013.01); A61K 31/4375 (2013.01); A61K 31/44 (2013.01); A61K 31/4439 (2013.01); A61K 31/451 (2013.01); A61K 31/4545 (2013.01); A61K 31/472 (2013.01); A61K 31/519 (2013.01); A61K 31/55 (2013.01); A61K 33/243 (2019.01); A61P 35/00 (2018.01); C07C 211/40 (2013.01); C07C 233/58 (2013.01); C07C 255/46 (2013.01); C07D 207/09 (2013.01); C07D 207/335 (2013.01); C07D 209/44 (2013.01); C07D 211/18 (2013.01); C07D 211/34 (2013.01); C07D 213/38 (2013.01); C07D 217/26 (2013.01); C07D 223/16 (2013.01); C07D 231/12 (2013.01); C07D 233/64 (2013.01); C07D 249/06 (2013.01); C07D 249/08 (2013.01); C07D 257/04 (2013.01); C07D 261/20 (2013.01); C07D 263/56 (2013.01); C07D 271/06 (2013.01); C07D 277/28 (2013.01); C07D 413/04 (2013.01); C07D 413/06 (2013.01); C07D 413/10 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01);
Abstract
A cyclopropylamine compound as a lysine-specific demethylase 1 (LSD1) inhibitor. Particularly, the present invention relates to a compound represented by formula (I) and a pharmaceutically acceptable salt thereof. The present invention also provides an application of the same in preparing a drug for treating an LSD1-related disease.
Wu, Lingyun. (2022). Lsd1 inhibitor and preparation method and application thereof (U.S. Patent No. 11433053). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11433053
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile